Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prevention of iatrogenic hyponatraemia in hospitalized children receiving intravenous maintenance fluids
ACTRN12609000924257Phase 3Recruiting
- Sponsor
- The Royal Children's Hospital
- Start
- Dec 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in hyponatraemia comparing Plasma-Lyte 148 with 5% dextrose with 0.45% sodium chloride with 5% dextrose (2 arms). Primary endpoint: Hyponatraemia incidence. Started Dec 2009; status: recruiting.
02
Drugs
plasma-lytesodium chloride
03
Conditions
hyponatraemia
Beyond the preview
Go deeper on ACTRN12609000924257.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12609000924257.